Automated description from the Alliance of Genome Resources (Release 7.0.0)
Enables PH domain binding activity and insulin receptor substrate binding activity. Acts upstream of or within negative regulation of insulin receptor signaling pathway and regulation of peptidyl-tyrosine phosphorylation. Predicted to be located in nucleus. Is expressed in several structures, including early conceptus; genitourinary system; and neural ectoderm. Orthologous to human ZNF592 (zinc finger protein 592).